Best Immunotherapy Treatment Hospitals Worldwide

At Prince Court Medical Centre, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 2007, the MSQH accredited hospital in Kuala Lumpur, Malaysia has 277 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Choosing BLK-Max Super Speciality Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 1959, the JCI, NABH accredited hospital is located in Delhi, India and operates 650 beds with modern oncology infrastructure.

Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.

Parkway Pantai provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1974, the JCI, MSQH accredited hospital is based in Kuala Lumpur, Malaysia and has 499 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Artemis Health Institute provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2007, the JCI, NABH accredited hospital is based in Gurgaon, India and has 750 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Sunway Medical Centre provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 1999, the ACHS accredited hospital is located in Kuala Lumpur, Malaysia and operates 724 beds with advanced oncology and infusion-care facilities.

Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.

Bangpakok 9 International Hospital offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 2003, the JCI, GHA accredited hospital is situated in Bangkok, Thailand and has 300 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.

Choosing Medipol Bahçelievler Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2022, the JCI accredited hospital is located in Istanbul, Turkey and operates 441 beds with modern oncology infrastructure.

Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.

Medanta - The Medicity provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2009, the JCI, NABH accredited hospital is located in Gurgaon, India and operates 1250 beds with advanced oncology and infusion-care facilities.

Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.

ParkCity Medical Centre provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2012, the JCI accredited hospital is based in Kuala Lumpur, Malaysia and has 300 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Gleneagles Hospital Mumbai provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1996, the JCI accredited hospital is based in Mumbai, India and has 450 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

At Subang Jaya Medical Centre, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 1985, the JCI accredited hospital in Kuala Lumpur, Malaysia has 442 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.

Max Super Specialty Hospital, Vaishali provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2008, the NABL, NABH accredited hospital is located in Ghaziabad, India and operates 370 beds with advanced oncology and infusion-care facilities.

Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.

Max Hospital, Gurgaon provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2007, the ISO, NABH, NABL accredited hospital is based in Gurgaon, India and has 104 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Indraprastha Apollo Hospital offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1996, the JCI accredited hospital is situated in Delhi, India and has 710 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.

Apollo Hospitals provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1988, the JCI accredited hospital is based in Hyderabad, India and has 550 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.